切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2013, Vol. 07 ›› Issue (02) : 91 -95. doi: 10.3877/cma.j.issn.1647-0793.2013.02.003

所属专题: 文献

论著

高迁移率族蛋白HMGA1在肝细胞癌及胆管细胞癌中的表达差异及临床意义
余元龙1, 周仕海2,(), 陈宏2, 胡泽民3, 邓辉洲2   
  1. 1. 528403 中山,中山大学附属中山医院器官移植科
    2. 528403 中山,中山大学附属中山医院普外三科
    3. 528403 中山,中山大学附属中山医院普外一科
  • 收稿日期:2012-07-01 出版日期:2013-04-01
  • 通信作者: 周仕海
  • 基金资助:
    中山市科技计划资助项目(20082A051)

Different expression of HMGA1 in hepatocarcinoma and intrahepatic cholangiocarcinoma and its significance

Yuan-long YU1, Shi-hai ZHOU2,(), Hong CHEN2, Ze-min HU3, Hui-zhou DENG2   

  1. 1. Department of Organ Transplantation, Zhongshan Hospital Affiliated to Sun Yat-sen University, Zhongshan 528403, China
  • Received:2012-07-01 Published:2013-04-01
  • Corresponding author: Shi-hai ZHOU
  • About author:
    Corresponding author: ZHOU Shi-hai, Email:
引用本文:

余元龙, 周仕海, 陈宏, 胡泽民, 邓辉洲. 高迁移率族蛋白HMGA1在肝细胞癌及胆管细胞癌中的表达差异及临床意义[J/OL]. 中华普通外科学文献(电子版), 2013, 07(02): 91-95.

Yuan-long YU, Shi-hai ZHOU, Hong CHEN, Ze-min HU, Hui-zhou DENG. Different expression of HMGA1 in hepatocarcinoma and intrahepatic cholangiocarcinoma and its significance[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(02): 91-95.

目的

探讨高迁移率族蛋白A1(HMGA1)在肝细胞癌(HCC)、肝内胆管细胞癌(IHC)中的表达差异和临床意义。

方法

采用免疫组化SABC法对60例HCC、42例胆管细胞癌及10例正常肝脏组织标本中HMGA1的表达情况进行检测,并分析其与临床病理特点之间的关系。

结果

HMG组A1在10例正常肝脏组织中无一例表达,在HCC组中表达率为3.3%(2/60),在IHC组中表达率为66.7%(28/42)。IHC组与HCC组中HMGA1表达差异有统计学意义(P = 0.000);IHC组HMGA1与p53的表达呈正相关(r = 0.673,P<0.05);1年内死亡患者的HMGA1表达水平(80.0%)较1年内存活患者的(33.3%)高,差异有统计学意义(P < 0.05)。

结论

HMGA1可作为鉴别肝细胞癌与肝内胆管细胞癌的一个潜在指标。HMGA1在肝内胆管细胞癌的生成中可能发挥了重要作用,HMGA1在肝内胆管细胞癌的高表达提示预后不良。

Objective

To investigate the expression of HMGA1 in hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma(IHC) and its significance.

Methods

Immunohistochemistry (SABC method) was applied to detect HMGA1 expression in 60 HCC, 42 IHC, and 10 normal hepatic tissues. The relationship between HMGA1 expresssion and clinicpathological features of HCC and IHC was determined.

Results

No significant nuclear immunoreactivity was found in normal hepatic tissues, while 3.3% (2/60) of HCC, 66.7% (28/42) of IHC showed positive immunoreactivity, and there was significant difference between HCC and IHC(P = 0.000). The expression level of HMGA1 was strongly correlated with the expression level of p53 (r = 0.673, P < 0.05). The expression of HMGA1 in patients who died in one year (80.0%) was higher than that of patients lived(33.3%), and the difference was significant(P < 0.05).

Conclusions

HMGA1 protein level may serve as a potential diagnostic marker that differentiate HCC from IHC. HMGA1 may play an important role in the development of IHC. The high expression level of HMGA1 in IHC is strongly correlated with bad prognosis.

图1 正常肝脏组织中无HMGA1表达(DAB ×400)
图2 HMGA1在肝细胞癌中表达呈阴性(DAB ×400)
图3 HMGA1在肝细胞癌中表达呈阳性(DAB ×400)
图4 HMGA1在肝内胆管细胞癌中表达呈阴性(DAB ×400)
图5 HMGA1在肝内胆管细胞癌中表达呈阳性(DAB ×400)
表1 肝内胆管细胞癌中HMGA1的表达与临床病理的联系
表2 p53与HMGA1在肝内胆管细胞癌肝组织中的表达(例)
1
Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem, 1973, 38(1): 14-19.
2
Reeves R, Adair JE. Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Repair(Amst), 2005, 4(8): 926-938.
3
Hoyos JM, Fedele M, Battista S, et al. Identification of genes up-and down-regulation by the high mobility group A1(HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res, 2004, 64(16): 5728-5735.
4
Fedele M, Battista S, Manfioletti G, et al. Role of the mobility group A proteins in human lipomas. Carcinogenesis, 2001, 22(10): 1583-1591.
5
Thanos M, Maniatis T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell, 1995, 83(7): 1091-1100.
6
Masciullo V, Baldassarre G, Pentimalli F, et al. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis, 2003, 24 (7): 1191-1198.
7
Takaha N, Resar LM, Vindivich D, et al. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. Prostate, 2004, 60(2): 160-167.
8
Fedele M, Bandiera A, Chiappetta G, et al. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins1. Cancer Res, 1996, 56(8): 1896-1901.
9
Abe N, Watanabe T, Masaki T, et al. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res, 2000, 60(12): 3117-3122.
10
Sarhadi VK, Wikman H, Salmenkivi K, et al. Increased expression of high mobility group A proteins in lung cancer. J Pathol, 2006, 209(2): 206-212.
11
Chiappetta G, Tallini G, De Biasio MC, et al. Detection of high mobility group I(Y) HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res, 1998, 58(18): 4193-4198.
12
Chang ZG, Yang LY, Wang W, et al. Determination of high mobility group A1(HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker. Dig Dis Sci, 2005, 50(10): 1764-1770.
13
Chuma M, Saeki N, Yamamoto Y, et al. Expression profiling in hepatocellular carcinoma with intrahepatic metastasis: identification of high-mobility group I(Y) protein as a molecular marker of hepatocellular carcinoma metastasis. Keio J Med, 2004, 53 (2): 90-97.
14
Abe N, Watanabe T, Izumisato Y, et al. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: Its potential use in the diagnosis of liver neoplasms. J Gastroenterol, 2003, 38(12): 1144-1149.
15
石景森,王炳煌. 胆道外科基础与临床. 北京:人民卫生出版社, 2003: 132-133.
16
Stanley RH, Lauri AA. Pathology and genetics of tumours of the digestive system. World Health Organization, International Agency for Research on Cancer, 2000: 180.
17
Pierantoni GM, Rinaldo C, Esposito F, et al. High mobility group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ, 2006, 13(9):1554-1563.
18
Esposito F, Tornincasa M, Chieffi P, et al. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. Cancer Res, 2010, 70(13): 5379-5388.
19
Frasca F, Rustighi A, Malaguarnera R, et al. HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res, 2006, 66(6): 2980-2989.
[1] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[2] 张金华, 赵锁. 早期ICC腹腔镜肝切除术不同淋巴结清扫范围的近远期效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 578-581.
[3] 刘炯, 彭乐, 马伟, 江斌. 鞘外解剖肝蒂技术治疗肝内胆管细胞癌的疗效评估[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 373-376.
[4] 黄小龙, 林师佈, 韩霖, 陈有科, 杨彦. 不同淋巴结清扫范围的肝内胆管细胞癌根治性切除术的预后研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(04): 401-404.
[5] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[6] 司钦亮, 毕世龙, 焦慧骁, 李世照, 陈哲禹, 武玉东. 精索去分化脂肪肉瘤两例并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 585-590.
[7] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[8] 黄俊豪, 陈宗杰, 胡添松. 血小板相关参数对肝内胆管细胞癌根治性切除患者预后预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 308-312.
[9] 李斌奎. 不可切除肝内胆管细胞癌的转化治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 511-516.
[10] 廖承煜, 江斌华, 黄龙, 王丹凤, 田毅峰, 陈实. 腹腔镜下肝左叶肝内胆管细胞癌根治术优化三步法的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 395-400.
[11] 杨发才, 游川, 雷正清, 李伟男, 段安琪, 邱应和, 李敬东, 程张军. 肿瘤负荷评分联合淋巴结分期对肝内胆管细胞癌患者术后生存预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 389-394.
[12] 于小鹏, 陈晨, 陈家璐, 童焕军, 邱应和, 吴泓, 宋天强, 何宇, 毛先海, 翟文龙, 程张军, 李敬东, 耿智敏, 汤朝晖. 肝内胆管细胞癌淋巴结清扫患者生存获益的术前临床病理特征[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 278-283.
[13] 杨小周, 赵华栋. N6-甲基腺苷表观转录组学在原发性肝癌中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 239-242.
[14] 吴添庆, 王炯亮, 郑梽楷, 李文轩, 周仲国. 经动脉放疗栓塞术治疗不可切除肝内胆管细胞癌疗效与安全性Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 190-195.
[15] 牛文博, 吴凤鹏, 刘月平, 周超熙, 张娟, 胡旭华, 李保坤, 王贵英. 新辅助放化疗对局部进展期直肠癌疗效及肿瘤免疫微环境变化的研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(05): 519-523.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?